Asia Pacific Finance Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Pacific Finance Daily.

Press releases published on August 14, 2026

Aug. 14, 2026

LanzaTech Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 14, 2026

SurgePays Reports Q2 2026 Revenue Growth of 40.7% Year-Over-Year to $16.2 Million, Reports Positive Net Income of $1.29 Million

Indeterminate GlobeNewswire

Aug. 14, 2026

Merifund Capital Management Releases Analysis on Saudi Aramco Q2 Financial Performance Amid Hormuz Disruptions

Indeterminate GlobeNewswire

Aug. 14, 2026

Beneficient Reports First Quarter Fiscal 2027 Results

Indeterminate GlobeNewswire

Aug. 14, 2026

Base Carbon Reports Second-Quarter 2026 Operating and Financial Results

Indeterminate GlobeNewswire

Aug. 14, 2026

Milestone Scientific Reports Financial Results for Second Quarter 2026

Indeterminate GlobeNewswire

Aug. 14, 2026

Super League Reports Second Quarter 2026 Financial Results, Highlighted by Improving Margins and Operating Performance

Indeterminate GlobeNewswire

Aug. 14, 2026

Edible Garden Reports Second Quarter 2026 Results; Revenue Grows 12.8%, Sales Increase 31.2% as Company Accelerates Farm-to-Formula® Strategy

Indeterminate GlobeNewswire

Aug. 14, 2026

WRAP Selected by WOFT to Support Florida’s $475,000 Teacher Safety Training Initiative

Indeterminate GlobeNewswire

Aug. 14, 2026

BridgeBio Pharma Announces Pricing of Oversubscribed Secondary Offering that Diversifies its Institutional Shareholder Base

Indeterminate GlobeNewswire

Aug. 14, 2026

Diginex Limited Announces Extraordinary General Meeting to Approve Proposed Acquisition of Resulticks

Indeterminate GlobeNewswire

Aug. 14, 2026

Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

Aug. 14, 2026

Outlook Therapeutics Reports Third Quarter Fiscal Year 2026 Financial Results and Provides Business Update Highlighting FDA Approval of LYTENAVA™

Indeterminate GlobeNewswire

Aug. 14, 2026

Saputo Enters Agreement to Sell its United Kingdom Operations

Indeterminate GlobeNewswire

Aug. 14, 2026

Saputo Enters Agreement to Sell its United Kingdom Operations

Indeterminate GlobeNewswire

Aug. 14, 2026

Saputo conclut une entente en vue de la vente de ses activités au Royaume-Uni

Indeterminate GlobeNewswire

Aug. 14, 2026

Tvardi Therapeutics Announces Second Quarter 2026 Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 14, 2026

Beyond Meat Announces Effectiveness of 1-for-30 Reverse Stock Split

Indeterminate GlobeNewswire

Aug. 14, 2026

PowerCompute Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 14, 2026

Quantum BioPharma Strengthens Equity and Liquidity in Q2 2026 as FDA Approves Lucid-MS for Pivotal Phase 2 Clinical Trial

Indeterminate GlobeNewswire